Name: 글로벌 시장 동향
SKU: DMMD1450
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 대동맥 내 풍선 펌프(IABP) 시장 규모는 2022년 XX백만 달러였으며, 2030년까지 XX백만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 XX%입니다.
대동맥 내 풍선 펌프(IABP)는 심장에 일시적인 심장 기능을 보조하는 기계 장치입니다. 대동맥 내부에 작은 풍선을 팽창시켜 심장 및 기타 장기로의 혈류를 증가시키는 방식으로 작동합니다. IABP는 일반적으로 심부전이나 심인성 쇼크와 같은 심각한 심장 질환 환자에게 사용되며, 보통 사타구니의 대퇴동맥을 통해 삽입된 카테터를 통해 삽입됩니다. IABP는 일반적으로 수술이나 약물 치료와 같은 다른 치료법으로 환자의 상태가 호전될 때까지 일시적으로 사용됩니다.

시장 동향
전 세계 대동맥 내 풍선 펌프(IABP) 시장 성장은 불안정형 협심증 및 심근경색과 같은 관상동맥 질환 증가, 심혈관 질환 유병률 급증, 비만 인구 증가, 생활습관병의 심화, 그리고 발전하는 글로벌 의료 인프라에 의해 주도되고 있습니다.
심혈관 질환 증가가 시장 성장을 견인합니다.
심혈관 질환 유병률의 급증과 기술 발전은 전 세계 시장 성장을 견인하고 있습니다. 2022년 StatPearls에 발표된 기사에 따르면, 관상동맥 질환(CAD)은 가장 흔한 심장 질환입니다. 이는 심장에 혈액을 공급하는 혈관의 죽상경화성 변화로 인해 발생합니다. CAD는 무증상 죽상경화증 및 안정형 협심증에서 급성 관상동맥 증후군(불안정형 협심증, NSTEMI, STEMI)에 이르기까지 다양한 임상 질환을 포괄합니다. 미국에서는 여전히 주요 사망 원인 중 하나입니다. 위험 요인에 대한 초기 평가는 관상동맥 질환 예방의 첫 번째 단계입니다.

만성 안정형 협심증은 서구 국가에서 인구 백만 명당 약 3만~4만 명에게 영향을 미칩니다. 남녀 모두에서 유병률은 나이가 들수록 증가합니다. 45~64세 남성과 여성의 유병률은 각각 4~7%와 5~7%입니다. 65~84세 남성과 여성의 유병률은 각각 14~15%와 10~12%로 추정됩니다.
대동맥 내 풍선 펌프(IABP)는 관상동맥 혈류를 증가시키고 좌심실 부하를 감소시켜 심장에 대한 산소 공급 균형을 개선하고 허혈 영역을 줄이며 심근세포의 괴사를 방지할 수 있습니다. 이 기술은 좌심실 기능에 중요한 일시적 지원을 제공하고 허혈성 심부전을 예방하는 데 도움이 되어 관상동맥 우회술과 관련된 수술 전후 사망률을 감소시킬 수 있습니다.

대동맥 내 풍선 펌프(IABP)와 관련된 부작용은 시장 성장을 저해할 수 있습니다.
그러나 대동맥 내 풍선 펌프(IABP)는 일반적으로 안전한 것으로 간주되지만, 사용과 관련된 몇 가지 잠재적인 부작용 및 합병증이 있습니다. 여기에는 동맥 또는 혈관 합병증이 포함될 수 있습니다. 여기에는 카테터 삽입 부위의 출혈, 혈종 또는 천공이 포함될 수 있습니다. 감염은 모든 침습적 시술과 마찬가지로 카테터 삽입 부위에 감염 위험이 있습니다. 혈전이 풍선이나 카테터에 형성되어 혈류를 차단할 수 있습니다. 부정맥은 IABP가 불규칙한 심장 박동을 유발할 수 있으며, 이는 일부 환자에게 위험할 수 있습니다. 심장 또는 폐 손상은 드물게 발생할 수 있습니다. 신장 손상은 IABP가 신장으로 가는 혈류를 감소시켜 신장 손상을 유발할 수 있습니다. 사지 허혈은 IABP가 카테터가 삽입된 사지로 가는 혈류를 감소시킬 수 있습니다.

COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 심장 수술에 상당한 영향을 미쳤습니다. 많은 병원들이 COVID-19 환자 치료를 위해 응급 상황이 아닌 수술, 특히 심장 수술을 축소하거나 중단해야 했습니다. 이로 인해 수술 건수가 감소하고 수술 대기 환자 수가 늘어났습니다. 2021년 '심혈관 질환 학회지(Archives of Cardiovascular Diseases)'에 발표된 논문에 따르면, 심장 수술은 수술 후 집중 치료가 필수적입니다. 하지만 이러한 전문 병동이 호흡기 지원이 필요한 COVID-19 환자 전용으로 사용되면서, 프랑스의 거의 모든 병원에서 선택적 개심술이 크게 지연되었습니다.
또한, 일부 심장 질환 환자는 기저 심장 질환으로 인해 COVID-19 감염 시 중증 질환 위험이 더 높을 수 있어 치료를 꺼리는 경향이 있습니다. 팬데믹으로 인해 심근경색으로 입원하는 환자 수도 감소했는데, 이는 사람들이 COVID-19 감염에 대한 두려움 때문에 병원을 찾지 않았기 때문으로 분석됩니다. 이로 인해 병원 수익이 감소했고, 심장 관련 서비스를 포함한 일부 서비스의 축소가 발생했습니다.

전반적으로, 코로나19 팬데믹은 전 세계 심장 수술에 상당한 영향을 미쳐 수술 건수 감소와 수술 대기 환자 적체, 의료진 및 장비 부족, 병원 수익 감소 등을 초래했습니다.
세그먼트 분석
대동맥 내 풍선 펌프(IABP) 카테터 부문은 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
대동맥 내 풍선 펌프(IABP) 카테터 부문은 가장 높은 시장 점유율을 차지하고 있습니다. 대동맥 내 풍선 펌프(IABP)는 심근경색과 같은 심장 질환 발생 시 심장과 뇌 등 주요 장기로의 혈류를 증가시키는 데 도움을 주는 장치입니다. 이 장치는 환자의 대동맥에 삽입되는 카테터와 환자의 심장 박동에 맞춰 팽창 및 수축하는 작은 풍선으로 구성됩니다. 이 장치는 심장 박동 주기의 이완기 동안 신체 주요 장기로 공급되는 혈액량을 증가시키는 데 도움을 줍니다. IABP는 심장 질환에 대한 일시적인 치료법으로 사용됩니다. 이 침습적 시술은 중환자실과 심장 카테터 시술실에서 시행됩니다.
또한, 메릴 라이프 사이언스는 하행 대동맥에 삽입하는 장치인 대동맥 내 풍선 카테터 키트를 제공합니다. 이완기 동안 대동맥 내 풍선이 팽창하고 수축기 동안 수축함으로써 심장 근육으로의 혈액 공급이 증가하고 좌심실의 부담이 감소합니다.
지역 분석
북미 지역은 전 세계 대동맥 내 풍선 펌프 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 대동맥 내 풍선 펌프 시장을 주도하고 있으며 예측 기간 동안에도 이러한 추세가 지속될 것으로 예상됩니다. 북미 지역의 기술 발전, 심장 질환 유병률 증가, 그리고 시장 참여 기업들의 신제품 출시가 시장 성장을 견인하고 있습니다.

매년 90만 명 이상의 미국인이 심장마비를 겪거나 심장 질환으로 급사합니다. 또한 급성 관상동맥 증후군으로 인해 매년 40만 명 이상이 사망합니다. 사망자의 약 3분의 2는 남성이며, 거의 모든 환자에게 기저 관상동맥 질환이 있습니다.
심장 질환 및 뇌졸중 예방 협회(Heart Disease and Stroke Prevention)에 따르면, 매년 약 69만 7천 명의 미국인이 심장 질환으로 사망하며, 이는 전체 사망자의 5분의 1에 해당합니다. 가장 흔한 심장 질환인 관상동맥 질환(CHD)으로 인해 매년 38만 2,820명 이상이 사망합니다. 매년 약 80만 5천 명의 미국인이 심장마비를 경험합니다. 이 중 60만 5천 명은 처음 심장마비를 겪는 경우이고, 20만 명은 이전에 심장마비를 경험한 적이 있는 경우입니다. 북미 지역에서 심장 관련 질환이 증가함에 따라 시장이 성장하고 있습니다.
경쟁 환경
대동맥 내 풍선 펌프 시장은 국내외 기업들이 경쟁하는 비교적 경쟁적인 시장입니다. 시장 성장에 기여하는 주요 기업으로는 Medtronic, Teleflex Incorporated, Abiomed Inc, Smiths Group plc, Getinge AB, ATMOS Medizin Technik GmbH & Co. KG, ARGON MEDICAL, Cook, MAQUET Holding B.V. & Co. KG, LivaNova PLC 등이 있습니다. 주요 기업들은 신제품 출시, 인수, 협력 등 다양한 성장 전략을 통해 전 세계 대동맥 내 풍선 펌프 시장의 성장을 견인하고 있습니다.

Medtronic
개요:
Medtronic은 1949년에 설립되어 미국에 본사를 둔 의료기기 회사입니다. 가장 복잡하고 어려운 질환에 대한 혁신적인 의료 기술 솔루션을 제공합니다.

제품 포트폴리오:
Euphora 반연성 풍선 카테터: Euphora 반연성 풍선 확장 카테터는 환자의 숙련도를 보완하고 환자가 가장 필요로 할 때 최상의 성능을 제공합니다.

글로벌 대동맥 내 풍선 펌프 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global intra-aortic balloon pump market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).
An intra-aortic balloon pump (IABP) is a mechanical device that provides temporary support to the heart. It works by inflating a small balloon inside the aorta, which helps to increase blood flow to the heart and other organs. The IABP is typically used in patients with severe heart problems, such as heart failure or cardiogenic shock, and is inserted through a catheter passed through an artery, usually the femoral artery in the groin. The IABP is typically used temporarily until other treatments, such as surgery or medication, can improve the patient's condition.
Market Dynamics
The global intra-aortic balloon pump market growth is driven by increasing cases of coronary artery diseases like unstable angina and myocardial infarction, the surging prevalence of cardiovascular diseases, a growing obese populace, advancing lifestyle disorders, and the evolving global healthcare infrastructure.
An increasing number of cardiovascular diseases drives the market growth
The surging prevalence of cardiovascular diseases and technological advancements drive the market worldwide. As per the article published in StatPearls in 2022, coronary artery disease (CAD) is the most frequent form of heart disease. It is the result of atheromatous differences in the vessels providing the heart. CAD represents a scope of clinical disorders, from asymptomatic atherosclerosis and stable angina to acute coronary syndrome (unstable angina, NSTEMI, STEMI). In the U.S., it is still one of the leading causes of mortality. Initial evaluation of risk factors is the first step in preventing coronary artery diseases.
Chronic stable angina affects approximately 30000 to 40000 people per million people in western countries. Prevalence rises with age in both men and women. The prevalence rates for men and women 45 to 64 years old are 4 to 7% and 5 to 7%, respectively. In men and women 65 to 84 years old, the estimated prevalence is 14 to 15% and 10 to 12%, respectively.
Intra-aortic balloon pumping can increase coronary blood flow and decrease left ventricular load, thereby improving the balance of oxygen supply to the heart, reducing the area of ischemia and protecting cardiomyocytes from dying. This technique could provide critical temporary support for the functioning of the left ventricle and help to prevent ischemic heart failure, thereby reducing peri-operative mortality associated with coronary artery bypass grafting.
The side effects associated with intra-aortic balloon pumps will hamper the growth of the market
However, the use of an intra-aortic balloon pump (IABP) is generally considered safe, but there are some potential side effects and complications associated with its use. These can include Arterial or vascular complications. These may include bleeding, hematoma, or puncture of the artery where the catheter is inserted. Infection as with any invasive process, there is a risk of infection at the site of the catheter insertion. Blood clots can form on the balloon or the catheter, blocking blood flow. Arrhythmias The IABP can cause irregular heartbeats, which can be dangerous for some patients. Heart or lung injury in rare cases, the IABP can cause injury to the heart or lungs. Kidney injury IABP can cause a decrease in blood flow to the kidneys, leading to kidney injury. Limb ischemia IABP may cause a decrease in blood flow to the limb in which the catheter was inserted.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant effect on cardiac surgery worldwide. Many hospitals have had to reduce or suspend non-emergency surgeries, including cardiac surgeries, to conserve resources for COVID-19 patients. This has reduced the number of surgeries performed and the backlog of patients waiting for surgery. As per the article published in the Archives of Cardiovascular Diseases in 2021, Cardiac surgery systematically requires postoperative intensive care. As these specialized units were reserved for patients with COVID-19 necessitating respiratory support, elective open-heart surgeries were substantially delayed in almost all French centers.
Furthermore, some cardiac patients may be at a higher risk of severe illness from COVID-19 due to underlying heart conditions, which may make them more hesitant to seek treatment. The pandemic also decreased the number of patients admitted to hospitals for heart attacks, which is believed to be due to people being afraid to seek medical attention out of fear of getting COVID-19. This decreased hospital revenue, resulting in some downsizing of services, including cardiac services.
Overall, the COVID-19 pandemic has had a significant impact on cardiac surgery worldwide, leading to a decrease in the number of surgeries being performed and a backlog of patients waiting for surgery, as well as affecting the availability of medical staff and equipment and leading to a decrease in revenue for hospitals.
Segment Analysis
The intra - aortic balloon pump (IABP) catheters segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The intra - aortic balloon pump (IABP) catheters segment accounts for the highest market share. An intra-aortic balloon pump (IABP) is a device to help increase blood flow to the body's vital organs, such as the heart and brain, during a cardiac event such as a heart attack. The device consists of a catheter inserted into the patient's aorta and a small balloon inflated and deflated in sync with the patient's heartbeat. This action helps to increase the amount of blood that is pumped to the body's vital organs during the diastolic phase of the heart's pumping cycle. IABP is used as a temporary measure for cardiac disorders. This invasive procedure is used in critical care units and cardiac catheterization labs.
In addition, Meril Life Sciences offers Intra Aortic Balloon Catheter Kit, a device placed in the descending aorta. Balloon inflation in the aorta during diastole and deflation during systole increase blood supply to the heart muscle and decrease the work of the left ventricle.
Geographical Analysis
North America region holds the largest market share of the global Intra-Aortic Balloon Pump market
North America dominates the market for Intra-Aortic Balloon Pumps and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of heart disease, and product launches by market players in the North American region drive the market.
Each year, more than 900,000 Americans suffer a heart attack or pass away suddenly from cardiac causes. In addition, acute coronary syndromes account for over 400,000 annual fatalities. About two-thirds are men, and almost all have underlying coronary artery disease.
According to Heart Disease and Stroke Prevention, about 697,000 Americans yearly, or 1 in every five deaths, are caused by heart disease. The most prevalent form of heart disease, coronary heart disease (CHD), claims the lives of over 382,820 people yearly. Approximately 805,000 Americans experience a heart attack each year. Six hundred and five thousand of these result in a first-time heart attack, while previous heart attacks cause 200,000. Rising heart-related disorders in the North American region drive the market.
Competitive Landscape
The intra-aortic balloon pump market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Medtronic, Teleflex Incorporated, Abiomed Inc, Smiths Group plc, Getinge AB, ATMOS Medizin Technik GmbH & Co. KG, ARGON MEDICAL, Cook, MAQUET Holding B.V. & Co. KG, LivaNova PLC, and Cook, among others. The major players are adopting several growth strategies, such as Type launches, acquisitions, and collaborations, contributing to the growth of the intra-aortic balloon pump market globally.
Medtronic
Overview:
Medtronic is a medical device company founded in 1949 and headquartered in the United States. Groundbreaking healthcare technology solutions for the most complex and challenging conditions.
Product Portfolio:
Euphora Semicompliant Balloon Catheter: Euphora semi-compliant balloon dilatation catheter complements the patient's expertise and provides uncompromising performance when the patient needs it most.
The global intra-aortic balloon pump market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

상세 목차

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Number of Heart Diseases
4.1.1.2. Technological Advancements
4.1.2. Restraints:
4.1.2.1. Risk of Inflammation while Inserting of The Balloon Pump
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Intra - Aortic Balloon Pump (IABP) Console*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Intra - Aortic Balloon Pump (IABP) Catheters
7.4. Introducer Tray
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
8.1.2. Market Attractiveness Index, By Indication
8.2. Coronary Artery Diseases*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Chronic Heart Failure
8.4. Heart Transplant
8.5. Cardiogenic Shock
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Ambulatory Surgery Clinics
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Type Benchmarking
12. Company Profiles
12.1. Medtronic*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Teleflex Incorporated
12.3. Abiomed Inc
12.4. Smiths Group plc
12.5. Getinge AB
12.6. ATMOS Medizin Technik GmbH & Co. KG
12.7. ARGON MEDICAL
12.8. MAQUET Holding B.V. & Co. KG
12.9. LivaNova PLC
12.10. Cook
LIST NOT EXHAUSTIVE
13. DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

Medtronic, Teleflex Incorporated, Abiomed Inc, Smiths Group plc, Getinge AB, ATMOS Medizin Technik GmbH & Co. KG, ARGON MEDICAL, MAQUET Holding B.V. & Co. KG, LivaNova PLC, Cook

표 목록 (Tables)

List of Tables

Table 01 Global Intra-Aortic Balloon Pump Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 02 Global Intra-Aortic Balloon Pump Market Value, By Indication Type, 2023, 2027 & 2031 ($ Million)

Table 03 Global Intra-Aortic Balloon Pump Market Value, By End-User, 2023, 2027 & 2031 ($ Million)

Table 04 Global Intra-Aortic Balloon Pump Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 05 Global Intra-Aortic Balloon Pump Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 06 Global Intra-Aortic Balloon Pump Market Value, By Product Type, 2022-2031 ($ Million)

Table 07 Global Intra-Aortic Balloon Pump Market Value, By Indication Type, 2023, 2027 & 2031 ($ Million)

Table 08 Global Intra-Aortic Balloon Pump Market Value, By Indication Type, 2022-2031 ($ Million)

Table 09 Global Intra-Aortic Balloon Pump Market Value, By End-User, 2023, 2027 & 2031 ($ Million)

Table 10 Global Intra-Aortic Balloon Pump Market Value, By End-User, 2022-2031 ($ Million)

Table 11 Global Intra-Aortic Balloon Pump Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 12 Global Intra-Aortic Balloon Pump Market Value, By Region, 2022-2031 ($ Million)

Table 13 North America Intra-Aortic Balloon Pump Market Value, By Product Type, 2022-2031 ($ Million)

Table 14 North America Intra-Aortic Balloon Pump Market Value, By Indication Type, 2022-2031 ($ Million)

Table 15 North America Intra-Aortic Balloon Pump Market Value, By End-User, 2022-2031 ($ Million)

Table 16 North America Intra-Aortic Balloon Pump Market Value, By Country, 2022-2031 ($ Million)

Table 17 South America Intra-Aortic Balloon Pump Market Value, By Product Type, 2022-2031 ($ Million)

Table 18 South America Intra-Aortic Balloon Pump Market Value, By Indication Type, 2022-2031 ($ Million)

Table 19 South America Intra-Aortic Balloon Pump Market Value, By End-User, 2022-2031 ($ Million)

Table 20 South America Intra-Aortic Balloon Pump Market Value, By Country, 2022-2031 ($ Million)

Table 21 Europe Intra-Aortic Balloon Pump Market Value, By Product Type, 2022-2031 ($ Million)

Table 22 Europe Intra-Aortic Balloon Pump Market Value, By Indication Type, 2022-2031 ($ Million)

Table 23 Europe Intra-Aortic Balloon Pump Market Value, By End-User, 2022-2031 ($ Million)

Table 24 Europe Intra-Aortic Balloon Pump Market Value, By Country, 2022-2031 ($ Million)

Table 25 Asia-Pacific Intra-Aortic Balloon Pump Market Value, By Product Type, 2022-2031 ($ Million)

Table 26 Asia-Pacific Intra-Aortic Balloon Pump Market Value, By Indication Type, 2022-2031 ($ Million)

Table 27 Asia-Pacific Intra-Aortic Balloon Pump Market Value, By End-User, 2022-2031 ($ Million)

Table 28 Asia-Pacific Intra-Aortic Balloon Pump Market Value, By Country, 2022-2031 ($ Million)

Table 29 Middle East & Africa Intra-Aortic Balloon Pump Market Value, By Product Type, 2022-2031 ($ Million)

Table 30 Middle East & Africa Intra-Aortic Balloon Pump Market Value, By Indication Type, 2022-2031 ($ Million)

Table 31 Middle East & Africa Intra-Aortic Balloon Pump Market Value, By End-User, 2022-2031 ($ Million)

Table 32 Medtronic: Overview

Table 33 Medtronic: Product Portfolio

Table 34 Medtronic: Key Developments

Table 35 Teleflex Incorporated: Overview

Table 36 Teleflex Incorporated: Product Portfolio

Table 37 Teleflex Incorporated: Key Developments

Table 38 Abiomed Inc : Overview

Table 39 Abiomed Inc : Product Portfolio

Table 40 Abiomed Inc : Key Developments

Table 41 Smiths Group plc: Overview

Table 42 Smiths Group plc: Product Portfolio

Table 43 Smiths Group plc: Key Developments

Table 44 Getinge AB: Overview

Table 45 Getinge AB: Product Portfolio

Table 46 Getinge AB: Key Developments

Table 47 ATMOS Medizin Technik GmbH & Co. KG: Overview

Table 48 ATMOS Medizin Technik GmbH & Co. KG: Product Portfolio

Table 49 ATMOS Medizin Technik GmbH & Co. KG: Key Developments

Table 50 ARGON MEDICAL, BD, Cook: Overview

Table 51 ARGON MEDICAL, BD, Cook: Product Portfolio

Table 52 ARGON MEDICAL, BD, Cook: Key Developments

Table 53 MAQUET Holding B.V. & Co. KG: Overview

Table 54 MAQUET Holding B.V. & Co. KG : Product Portfolio

Table 55 MAQUET Holding B.V. & Co. KG : Key Developments

Table 56 LivaNova PLC: Overview

Table 57 LivaNova PLC: Product Portfolio

Table 58 LivaNova PLC: Key Developments

Table 59 Cook: Overview

Table 60 Cook: Product Portfolio

Table 61 Cook: Key Developments

그림 목록 (Figures)

List of Figures

Figure 01 Global Intra-Aortic Balloon Pump Market Share, By Product Type, 2022 & 2031 (%)

Figure 02 Global Intra-Aortic Balloon Pump Market Share, By Indication Type, 2022 & 2031 (%)

Figure 03 Global Intra-Aortic Balloon Pump Market Share, By End-User, 2022 & 2031 (%)

Figure 04 Global Intra-Aortic Balloon Pump Market Share, By Region, 2022 & 2031 (%)

Figure 05 Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 06 Global Intra-Aortic Balloon Pump Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 07 Intra - Aortic Balloon Pump (IABP) Console: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 08 Intra - Aortic Balloon Pump (IABP) Catheters: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 09 Introducer Tray: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 10 Global Intra-Aortic Balloon Pump Market Y-o-Y Growth, By Indication Type, 2022-2031 (%)

Figure 11 Coronary Artery Diseases: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 12 Chronic Heart Failure: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 13 Heart Transplant: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 14 Cardiogenic Shock: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 15 Others: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 16 Global Intra-Aortic Balloon Pump Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 17 Hospitals: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 18 Ambulatory Surgery Clinics: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 19 Others: Global Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 20 Global Intra-Aortic Balloon Pump Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 21 North America Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 22 North America Intra-Aortic Balloon Pump Market Share, By Product Type, 2022 & 2031 (%)

Figure 23 North America Intra-Aortic Balloon Pump Market Share, By Indication Type, 2022 & 2031 (%)

Figure 24 North America Intra-Aortic Balloon Pump Market Share, By End-User, 2022 & 2031 (%)

Figure 25 North America Intra-Aortic Balloon Pump Market Share, By Country, 2022 & 2031 (%)

Figure 26 South America Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 27 South America Intra-Aortic Balloon Pump Market Share, By Product Type, 2022 & 2031 (%)

Figure 28 South America Intra-Aortic Balloon Pump Market Share, By Indication Type, 2022 & 2031 (%)

Figure 29 South America Intra-Aortic Balloon Pump Market Share, By End-User, 2022 & 2031 (%)

Figure 30 South America Intra-Aortic Balloon Pump Market Share, By Country, 2022 & 2031 (%)

Figure 31 Europe Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 32 Europe Intra-Aortic Balloon Pump Market Share, By Product Type, 2022 & 2031 (%)

Figure 33 Europe Intra-Aortic Balloon Pump Market Share, By Indication Type, 2022 & 2031 (%)

Figure 34 Europe Intra-Aortic Balloon Pump Market Share, By End-User, 2022 & 2031 (%)

Figure 35 Europe Intra-Aortic Balloon Pump Market Share, By Country, 2022 & 2031 (%)

Figure 36 Asia-Pacific Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 37 Asia-Pacific Intra-Aortic Balloon Pump Market Share, By Product Type, 2022 & 2031 (%)

Figure 38 Asia-Pacific Intra-Aortic Balloon Pump Market Share, By Indication Type, 2022 & 2031 (%)

Figure 39 Asia-Pacific Intra-Aortic Balloon Pump Market Share, By End-User, 2022 & 2031 (%)

Figure 40 Asia-Pacific Intra-Aortic Balloon Pump Market Share, By Country, 2022 & 2031 (%)

Figure 41 Middle East & Africa Intra-Aortic Balloon Pump Market Value, 2022-2031 ($ Million)

Figure 42 Middle East & Africa Intra-Aortic Balloon Pump Market Share, By Product Type, 2022 & 2031 (%)

Figure 43 Middle East & Africa Intra-Aortic Balloon Pump Market Share, By Indication Type, 2022 & 2031 (%)

Figure 44 Middle East & Africa Intra-Aortic Balloon Pump Market Share, By End-User, 2022 & 2031 (%)

Figure 45 Medtronic: Financials

Figure 46 Teleflex Incorporated: Financials

Figure 47 Abiomed Inc : Financials

Figure 48 Smiths Group plc: Financials

Figure 49 Getinge AB: Financials

Figure 50 ATMOS Medizin Technik GmbH & Co. KG: Financials

Figure 51 ARGON MEDICAL, BD, Cook: Financials

Figure 52 MAQUET Holding B.V. & Co. KG: Financials

Figure 53 LivaNova PLC: Financials

Figure 54 Cook: Financials

글로벌 대동맥 내 풍선 펌프 시장 – 2022-2029

Global Intra-Aortic Balloon Pump Market - 2022-2029